Previous close | 90.10 |
Open | 90.10 |
Bid | 91.00 |
Ask | 97.90 |
Strike | 420.00 |
Expiry date | 2023-02-17 |
Day's range | 90.10 - 90.10 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Humana ( NYSE:HUM ) Full Year 2022 Results Key Financial Results Revenue: US$92.9b (up 10% from FY 2021). Net income...
Top health insurance company Humana (NYSE: HUM) wasn't necessarily tops with investors on Wednesday. After reporting its latest set of quarterly figures, the company's share price bumped slightly higher, by 0.3%, which wasn't high enough to beat the S&P 500 index's more than 1% increase. It's not that Humana's results for the fourth quarter 2022 were bad or uninspiring; it's just that they didn't excel.
Humana's (HUM) fourth-quarter results benefit from solid premiums from its individual Medicare Advantage business and the sound performance of the two newly formed segments.